- Investing Ideas
- /
- Bangladeshi Pharmaceuticals & Biotech Undervalued over 20% based on DCF
Bangladeshi Pharmaceuticals & Biotech Undervalued over 20% based on DCF
Results
3
0 new
Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.
3 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
SQURPHARMA | ৳224.00 | 1.0% | 6.3% | ৳198.6b | ৳322.80 | PE9.8x | E12.6% | 4.9% | ||
IBNSINA | ৳309.20 | -2.3% | 7.9% | ৳9.7b | ৳390.00 | PE14.4x | E20.8% | 2.0% | ||
ADVENT | ৳16.20 | -9.0% | -28.6% | ৳1.5b | n/a | PE16.3x | n/a | 1.2% |
Page 1 of 1